Ibnsina Pharma leads Egypt’s pharmaceutical distribution market with 31.1% share in H1 2025
Updated 9/14/2025 11:41:00 AM
Arab Finance: Ibnsina Pharma has retained its leading position among pharmaceutical distributors in Egypt, with a 31.1% market share in the first half (H1) of 2025, according to IQVIA reports.
The company has steadily strengthened its dominance, growing from a 24.2% share in 2023 to 30.8% in 2024.
IQVIA data also showed Ibnsina Pharma ranked first in the pharmacy and wholesale sector, holding a 35% share of a segment that accounts for 69% of the overall drug market.
The company further maintained its lead as the largest private distributor to public and private hospitals, capturing 22.3% of a sector representing around 31% of the market.
IQVIA reported that Egypt’s pharmaceutical market reached sales of EGP 186.7 billion in H1 2025, up from EGP 119.6 billion a year earlier, marking a 56% growth rate following drug price adjustments linked to the 2024 currency devaluation.
Ibnsina Pharma recorded revenue growth of 54.8% in H1 of 2025, with revenues reaching EGP 35 billion compared to EGP 22.8 billion in the same period of 2024.
Related News
